A Drug For Skin Cancer Could Benefit Patients With Leukemia, New Research Says

A drug used to combat skin cancer could also benefit patients suffering from Hairy Cell Leukemia (HCL) according to the latest study published in the New England Journal of Medicine (NEJM). Vemurafenib is a drug belongs to BRAF inhibitor group, approved for the treatment of advanced state melanomas and leukemia (blood cancer). It is possible … Continue reading A Drug For Skin Cancer Could Benefit Patients With Leukemia, New Research Says

Gazyva (obiutumab) Approved by FDA To Treat Chronic Lymphocytic Leukemia Patients

Gazyva (obiutumab) has been approved by U.S Food and Drug Administration (FDA) to treat patients suffering from chronic lymphocytic leukemia (CLL) in combination with chlorambucil. It has been estimated by National Cancer Institute that nearly 15,680 people will be diagnosed and 4,580 will die due to CLL in America in 2013.

FDA Approved Drugs to Treat Hematological Disorders in 2017

Following drugs were approved by US Food and Drug Administration (FDA) in 2017 to treat numerous hematological disorders such as hemophilia, leukemia, sickle cell disease and etc. No. Brand Name Generic Name Therapeutic Uses Manufactured By Approval Date 01 Aliqopa Copanlisib Follicular Lymphoma Bayer September 2017 02 Besponsa Inotuzumab Ozogamicin Adults With Relapsed Or Refractory B-Cell Precursor Acute … Continue reading FDA Approved Drugs to Treat Hematological Disorders in 2017

Difference Between CT Scan And PET Scan

Computed tomography (CT) and Positron Emission Tomography (PET) are frequently used to investigate numerous human diseases such as disorder of bones, central nervous system. cardiac system, cancer and etc. There are some comprehensible differences between CT scan and PET as discussed in the following table. Parameters CT Scan PET Scan Acronym Abbreviated as computed tomography Abbreviated … Continue reading Difference Between CT Scan And PET Scan